Franco-Moreno, A.; Madroñal-Cerezo, E.; Martínez-Casa-Muñoz, A.; Ortiz-Sánchez, J.; Ancos-Aracil, C.L.
Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update. Pharmaceutics 2025, 17, 342.
https://doi.org/10.3390/pharmaceutics17030342
AMA Style
Franco-Moreno A, Madroñal-Cerezo E, Martínez-Casa-Muñoz A, Ortiz-Sánchez J, Ancos-Aracil CL.
Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update. Pharmaceutics. 2025; 17(3):342.
https://doi.org/10.3390/pharmaceutics17030342
Chicago/Turabian Style
Franco-Moreno, Anabel, Elena Madroñal-Cerezo, Ana Martínez-Casa-Muñoz, Judith Ortiz-Sánchez, and Cristina Lucía Ancos-Aracil.
2025. "Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update" Pharmaceutics 17, no. 3: 342.
https://doi.org/10.3390/pharmaceutics17030342
APA Style
Franco-Moreno, A., Madroñal-Cerezo, E., Martínez-Casa-Muñoz, A., Ortiz-Sánchez, J., & Ancos-Aracil, C. L.
(2025). Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update. Pharmaceutics, 17(3), 342.
https://doi.org/10.3390/pharmaceutics17030342